Literature DB >> 2314100

Improved survival after pulmonary resection of metastatic colorectal carcinoma.

E R Sauter1, J S Bolton, G W Willis, G H Farr, A Sardi.   

Abstract

While hepatic resection of metastatic colorectal carcinoma is accepted as effective in selected patients, resection of metastases to other solid organs has not gained wide acceptance. We retrospectively reviewed the records of 49 patients who had resection of isolated pulmonary (18 patients) and hepatic (31 patients) metastases from the large bowel, comparing disease-free survival and overall survival. Tumor parameters analyzed included Dukes' stage, deoxyribonucleic acid (DNA) flow cytometry, and number of metastases. Dukes' B and diploid tumors had longer disease-free survival and overall survival than did Dukes' C and aneuploid tumors, though the difference was not significant. Patients with a single lung metastasis had a significantly longer disease-free survival (P = .02) than did patients with multiple metastases. Mean and median survival were longer in patients with lung metastases. Five-year actuarial survival was 19% for patients with liver metastases and 47% for patients with lung metastases. Resection of isolated pulmonary metastases from the large intestine results in survival comparable to or better than resection of hepatic metastases. An aggressive surgical approach is warranted in patients with isolated resectable pulmonary metastases of colorectal carcinoma.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2314100     DOI: 10.1002/jso.2930430303

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  6 in total

1.  Does nodal status influence survival? Results of a 19-year systematic lymphadenectomy experience during lung metastasectomy of colorectal cancer.

Authors:  Stéphane Renaud; Marco Alifano; Pierre-Emmanuel Falcoz; Pierre Magdeleinat; Nicola Santelmo; Olivier Pagès; Gilbert Massard; Jean-François Régnard
Journal:  Interact Cardiovasc Thorac Surg       Date:  2014-01-16

2.  Surgery for pulmonary metastases from colorectal cancer: the importance of prethoracotomy serum carcinoembryonic antigen as an indicator of prognosis.

Authors:  Masahiko Higashiyama; Ken Kodama; Naozumi Higaki; Koji Takami; Kohei Murata; Masao Kameyama; Hideoki Yokouchi
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2003-07

3.  Evaluation of intraperitoneal lavage cytology before colorectal cancer resection.

Authors:  Shoichi Fujii; Hiroshi Shimada; Shigeru Yamagishi; Mitsuyoshi Ota; Chikara Kunisaki; Hideyuki Ike; Yasushi Ichikawa
Journal:  Int J Colorectal Dis       Date:  2009-05-28       Impact factor: 2.571

4.  Pulmonary enteric adenocarcinoma: a study of the clinicopathologic and molecular status of nine cases.

Authors:  Cai-Xia Wang; Biao Liu; Yan-Fen Wang; Ru-Song Zhang; Bo Yu; Zhen-Feng Lu; Qun-Li Shi; Xiao-Jun Zhou
Journal:  Int J Clin Exp Pathol       Date:  2014-02-15

5.  KRAS and BRAF mutations are prognostic biomarkers in patients undergoing lung metastasectomy of colorectal cancer.

Authors:  S Renaud; B Romain; P-E Falcoz; A Olland; N Santelmo; C Brigand; S Rohr; D Guenot; G Massard
Journal:  Br J Cancer       Date:  2015-02-17       Impact factor: 7.640

Review 6.  Current Evidence for Stereotactic Body Radiotherapy in Lung Metastases.

Authors:  Enrique Gutiérrez; Irving Sánchez; Omar Díaz; Adrián Valles; Ricardo Balderrama; Jesús Fuentes; Brenda Lara; Cipatli Olimón; Víctor Ruiz; José Rodríguez; Luis H Bayardo; Matthew Chan; Conrad J Villafuerte; Jerusha Padayachee; Alexander Sun
Journal:  Curr Oncol       Date:  2021-07-15       Impact factor: 3.677

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.